Furthermore, a study by EA Kogan revealed that in patients with COVID-19-related lung adenocarcinoma, the expression of ALDH1 was also significantly increased (Kogan et al., 2024). This evidence concerns the gene ALDH1A1 and lung adenocarcinoma.